Case Study

How Growthwell raised an eight-figure sum from Temasek


Innovation sometimes happens before profit

Bringing a never-before-seen meat replacement product into the market and seeking to incept the minds of investors is much easier said than done. On the crux of a breakthrough with Israel company ChickP, the Growthwell team were close to bringing to market the first non-allergenic, cruelty-free alternative. They just needed help to bring that story to life.
growthwell ipad mockup highspark chickpeas falling case study


Making the case for chickpeas as meat replacements

Raising purely with IP rights, without profits or any validated proof-of-concept is no easy feat. We worked with the team to isolate their key difference, create a commercial case for the product although the business has yet to generate any revenue at the time of fundraising.

The development and commercialisation of this solution requires a significant runway and cash to burn. Playing up team experience in F&B as well as a logistic network that could see their raw material circulated into restaurants was the best bet to tell a compelling story.


growthwell collage highspark case study.001


Backed by Singapore’s sovereign fund

Armed with their new story, in an unprecedented seed round, the Growthwell team drew interest from a stable of investors including Singapore’s sovereign fund: Temasek. They raised an eight-figure sum to grow their joint-ventures in Israel as well as to scale production for their chick-pea protein isolate to commercialise within SouthEast Asia. 

Seed Round


in funding

Series A Round


in funding

“We couldn’t have done it without HighSpark”.
We’re definitely coming back for our next round.
They have a knack for helping us find our ideal story”

Justin Chou

CEO, Growthwell, Fundraised $11M from Temasek